Table 2:
Anemia/Heart failure | 0/0 | +/0 | 0/+ | +/+ |
---|---|---|---|---|
Diagnostic/Interventional Procedures | (n=2,300) | (n=382) | (n=837) | (n=344) |
Cardiac catheterization | 60.0% | 38.5% | 37.5% | 26.5%** |
Coronary artery bypass grafting | 7.5% | 4.7% | 4.4% | 1.2%** |
Percutaneous coronary intervention | 40.2% | 23.3% | 21.4% | 16.0%** |
Medications | ||||
Angiotensin converting enzyme inhibitors/Angiotensin receptor blockers | 67.0% | 59.7% | 69.1% | 64.8%* |
Aspirin | 93.4% | 86.9% | 89.4% | 88.1%** |
Beta blockers | 90.0% | 90.8% | 87.0% | 87.5%* |
Lipid lowering medications | 74.7% | 73.8% | 65.7% | 66.9%** |
Cumulative number of cardiac medications | ||||
Any 2 medications | 18.4% | 22.3% | 22.1% | 25.9%* |
Any 3 medications | 30.6% | 30.1% | 32.9% | 29.4% |
All 4 medications | 51.0% | 47.6% | 45.0% | 44.8%* |
P<.01;
P<.001